XML 31 R22.htm IDEA: XBRL DOCUMENT v3.21.1
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Table)
7 Months Ended
Dec. 31, 2020
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)  
Schedule of quarterly financial information

 

 

 

 

 

 

 

 

 

 

 

    

As of September 30, 2020

 

 

As Previously

    

Restatement

    

 

 

 

 

Reported

 

Adjustment

 

As Restated

 

 

 

 

 

 

 

 

 

 

Balance Sheet

 

 

  

 

 

  

 

 

  

Total assets

 

$

545,356,337

 

$

 —

 

$

545,356,337

Liabilities and shareholders’ equity

 

 

  

 

 

  

 

 

  

Total current liabilities

 

$

144,624

 

$

 —

 

$

144,624

Deferred underwriting commissions

 

 

13,614,452

 

 

 —

 

 

13,614,452

Derivative warrant liabilities

 

 

 —

 

 

35,253,220

 

 

35,253,220

Total liabilities

 

 

13,759,076

 

 

35,253,220

 

 

49,012,296

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption shareholders’ equity

 

 

526,597,260

 

 

(35,253,220)

 

 

491,344,040

Preference shares - $0.0001 par value

 

 

 —

 

 

 —

 

 

 —

Class A ordinary shares - $0.0001 par value

 

 

174

 

 

352

 

 

526

Class B ordinary shares - $0.0001 par value

 

 

1,379

 

 

 —

 

 

1,379

Additional paid-in-capital

 

 

5,139,931

 

 

16,602,788

 

 

21,742,719

Accumulated deficit

 

 

(141,483)

 

 

(16,603,140)

 

 

(16,744,623)

Total shareholders’ equity

 

 

5,000,001

 

 

 —

 

 

5,000,001

Total liabilities and shareholders’ equity

 

$

545,356,337

 

$

 —

 

$

545,356,337

 

 

 

 

 

 

 

 

 

 

 

 

    

Three Months Ended September 30, 2020

 

 

As Previously

    

Restatement

    

 

 

 

 

Reported

 

Adjustment

 

As Restated

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Statement of Operations

 

 

  

 

 

  

 

 

  

Loss from operations

 

$

(126,442)

 

$

 —

 

$

(126,442)

Other (expense) income:

 

 

  

 

 

  

 

 

  

Change in fair value of derivative warrant liabilities

 

 

 —

 

 

(16,024,190)

 

 

(16,024,190)

Financing cost - derivative warrant liabilities

 

 

 —

 

 

(578,950)

 

 

(578,950)

Net gain from investments held in Trust Account

 

 

2,139

 

 

 —

 

 

2,139

Total other (expense) income

 

 

2,139

 

 

(16,603,140)

 

 

(16,601,001)

Net loss

 

$

(124,303)

 

$

(16,603,140)

 

$

(16,727,443)

 

 

 

 

 

 

 

 

 

 

Basic and Diluted weighted-average Class A ordinary shares outstanding

 

 

54,279,556

 

 

 

 

 

54,279,556

Basic and Diluted net loss per Class A share

 

$

 —

 

 

 

 

$

0.00

Basic and Diluted weighted-average Class B ordinary shares outstanding

 

 

12,935,010

 

 

 

 

 

12,935,010

Basic and Diluted net loss per Class B share

 

$

(0.01)

 

$

(1.28)

 

$

(1.29)

 

 

 

 

 

 

 

 

 

 

 

 

    

Period From June 12, 2020 (Inception) Through September 30, 2020

 

 

As Previously

    

Restatement

    

 

 

 

 

Reported

 

Adjustment

 

As Restated

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Statement of Operations

 

 

  

 

 

  

 

 

  

Loss from operations

 

$

(143,622)

 

$

 —

 

$

(143,622)

Other (expense) income:

 

 

  

 

 

  

 

 

  

Change in fair value of warrant liabilities

 

 

 —

 

 

(16,024,190)

 

 

(16,024,190)

Financing cost

 

 

 —

 

 

(578,950)

 

 

(578,950)

Net gain from investments held in Trust Account

 

 

2,139

 

 

 —

 

 

2,139

Total other (expense) income

 

 

2,139

 

 

(16,603,140)

 

 

(16,601,001)

Net loss

 

$

(141,483)

 

$

(16,603,140)

 

$

(16,744,623)

 

 

 

 

 

 

 

 

 

 

Basic and Diluted weighted-average Class A ordinary shares outstanding

 

 

54,279,556

 

 

 

 

 

54,279,556

Basic and Diluted net loss per Class A share

 

$

 —

 

 

 

 

$

 —

Basic and Diluted weighted-average Class B ordinary shares outstanding

 

 

12,935,010

 

 

 

 

 

12,935,010

Basic and Diluted net loss per Class B share

 

$

(0.01)

 

$

(1.28)

 

$

(1.29)

 

 

 

 

 

 

 

 

 

 

 

 

    

Period From June 12, 2020 (Inception) Through September 30, 2020

 

 

As Previously

    

Restatement

    

 

 

 

 

Reported

 

Adjustment

 

As Restated

 

 

 

 

 

 

 

 

 

 

Unaudited Condensed Statement of Cash Flows

 

 

  

 

 

  

 

 

  

Net loss

 

$

(141,483)

 

$

(16,603,140)

 

$

(16,744,623)

Adjustment to reconcile net loss to net cash used in operating activities

 

 

(307,061)

 

 

16,603,140

 

 

16,296,079

Net cash used in operating activities

 

 

(448,544)

 

 

 —

 

 

(448,544)

Net cash used in investing activities

 

 

(543,986,470)

 

 

 —

 

 

(543,986,470)

Net cash provided by financing activities

 

 

545,413,196

 

 

 —

 

 

545,413,196

Net change in cash

 

$

978,182

 

$

 —

 

$

978,182